JADE DARE trial met co-primary and key secondary endpoints and demonstrated a safety profile consistent with previous studies for moderate to severe atopic dermatitis
The data suggest that a booster dose given within 6 to 12 months after the second dose may help maintain a high level of protection against COVID-19.
The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT
If approved it will bring a second source of MMR vaccine to the US market
Deal signed with AOP Orphan for US commercial rights
Filing for WHO Emergency Use Authorisation this month
Deal for 100 million doses with additional 100 million through 2023
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Subscribe To Our Newsletter & Stay Updated
